• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Monday, January 18, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

UMMS scientists offer first look at how our cells can ‘swallow up and quarantine’ Zika

Bioengineer by Bioengineer
June 3, 2016
in Health
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE
Credit: Brass Lab

WORCESTER, MA – Eight weeks after receiving their first samples of Zika virus, scientists at the University of Massachusetts Medical School (UMMS) have shown that a very small protein we all have in our bodies, interferon-induced protein 3 (IFITM3), can dramatically reduce the ability of Zika virus to infect human and mouse cells. In some cases, IFITM3 can also prevent Zika virus from killing our cells. The findings, by senior author Abraham Brass, MD, PhD, assistant professor of microbiology & physiological systems, suggest that boosting the actions of IFITM3 may be useful for inhibiting Zika virus and other emerging viral infections. The study appears in the journal Cell Reports.

“This work represents the first look at how our cells defend themselves against Zika virus’ attack,” said Dr. Brass. “Our results show that Zika virus has a weakness that we could potentially exploit to prevent or stop infection.”

Previous studies by Brass and Paul Kellam, PhD, professor from the Wellcome Trust Sanger Institute in the UK, have shown that people who have a genetic variant, or allele, of the IFITM3 gene are more susceptible to the development of severe influenza. While relatively rare in people of European decent, this IFITM3 variant is more common in Asia and Micronesia. The current study suggests that it will be important to test whether this allele might contribute to the risk of more severe Zika virus infections and birth defects, according to Brass.

An expert in flaviviruses, a family of viruses transmitted by mosquitos that includes Zika, yellow fever, dengue and West Nile, Brass has developed a suite of genomic tools to probe how human cells respond to pathogens and how these invaders exploit host cell factors and proteins to replicate.

“Having these tools allowed us to respond quickly when the Zika virus threat emerged,” said Brass. “We simply adapted the technology we’d developed over the last four years working with dengue, influenza and other viruses to begin work on Zika virus.”

The mosquito-transmitted Zika virus typically causes relatively mild symptoms in infected adults. Prior to outbreaks of the virus in Micronesia and Southeast Asia in 2007 relatively few human cases had been reported. An ongoing epidemic of Zika virus began in early 2015 in Brazil and with it new evidence emerged that Zika virus infection of mothers during early pregnancy can result in microcephaly, a severe brain defect in infants.

There is no treatment for Zika virus infection. The best way to prevent the infection is to limit potential exposure to the infected mosquitos that carry the disease. As summer heats up and mosquito season gets under way, the World Health Organization expects the virus to spread throughout much of the Americas including parts of the United States.

From their earlier research on dengue virus and other flaviviruses related to Zika virus, Brass and his group had a hunch that IFITM3 might reduce or block viral infection. Using the IFITM3 tools and assays they’d developed for studying dengue and influenza viruses, the Brass lab was able to rapidly test IFITM3’s effect on Zika virus. “We just plugged Zika virus into our system and immediately began testing it,” said Brass. “What might have taken many months or longer to build, we were able to turn around in just several weeks.”

Found in nearly all human cells, IFITM3 works to alter the cell membrane, making it more difficult for viruses to penetrate this outer defense. The Brass lab found that when IFITM3 levels are low, Zika virus can more readily infiltrate into the cell interior and cause infection. Conversely, they discovered that when IFITM3 is abundant and on guard, it strongly prevents Zika virus from reaching the interior of the cell and so blocks its infection.

“In effect, we see that IFITM3 allows our cells to swallow up and quarantine the virus thereby stopping their own infection, and also the infection of neighboring cells” said George Savidis, a research associate in the Brass lab and the first author of the study. “We think this also reduces the levels of cell death caused by Zika virus.

“This work shows that IFITM3 acts as an early front line defender to prevent Zika virus from getting its hands on all of the resources in our cells that it needs to grow,” said Savidis. “IFITM3 pretty much keeps Zika virus stuck in no man’s land where it can’t do anything to harm us.”

The next step for Brass and his collaborators, including Sharone Green, MD, associate professor of medicine and a flavivirus expert at UMMS, is to test these findings in mice that are IFITM3-deficient to see whether these animals are more susceptible to the effects of Zika virus infection. The Brass lab is also searching for small molecules that can boost the levels, and hopefully the anti-viral actions, of IFITM3. Brass believes that such molecules could be developed into therapies to treat or protect us from Zika virus, as well as a growing list of other dangerous viruses.

“A lot of data by us and others in the field has shown that IFITM3 has a big impact on blocking many emerging viruses such as dengue, Zika, and Ebola” said Brass. “Given our recent results with Zika virus, it’s now even more important that we work to find out how IFITM3 is blocking these viruses, and use that knowledge to prevent and treat infections.”

###

About the University of Massachusetts Medical School

The University of Massachusetts Medical School (UMMS), one of five campuses of the University system, is comprised of the School of Medicine, the Graduate School of Biomedical Sciences, the Graduate School of Nursing, a thriving research enterprise and an innovative public service initiative, Commonwealth Medicine. Its mission is to advance the health of the people of the Commonwealth through pioneering education, research, public service and health care delivery with its clinical partner, UMass Memorial Health Care. In doing so, it has built a reputation as a world-class research institution and as a leader in primary care education. The Medical School attracts more than $266 million annually in research funding, placing it among the top 50 medical schools in the nation. In 2006, UMMS’s Craig C. Mello, PhD, Howard Hughes Medical Institute Investigator and the Blais University Chair in Molecular Medicine, was awarded the Nobel Prize in Physiology or Medicine, along with colleague Andrew Z. Fire, PhD, of Stanford University, for their discoveries related to RNA interference (RNAi). The 2013 opening of the Albert Sherman Center ushered in a new era of biomedical research and education on campus. Designed to maximize collaboration across fields, the Sherman Center is home to scientists pursuing novel research in emerging scientific fields with the goal of translating new discoveries into innovative therapies for human diseases.

Media Contact

Jim Fessenden
[email protected]
508-579-2934
@UMassMedNow

http://www.umassmed.edu

The post UMMS scientists offer first look at how our cells can ‘swallow up and quarantine’ Zika appeared first on Scienmag.

Share22Tweet7Share2ShareShareShare1

Related Posts

IMAGE

Many parents say teens with anxiety, depression may benefit from peer confidants at school

January 18, 2021
IMAGE

Scientists shed light on how and why some people report “hearing the dead”

January 18, 2021

Changing diets — not less physical activity — may best explain childhood obesity crisis

January 18, 2021

Rapid blood test identifies COVID-19 patients at high risk of severe disease

January 15, 2021
Next Post
blank

Repairing chronic wounds

blank

ASCO: Finally, targeted therapies for triple-negative breast cancer

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    The map of nuclear deformation takes the form of a mountain landscape

    53 shares
    Share 21 Tweet 13
  • Blood pressure drug may be key to increasing lifespan, new study shows

    44 shares
    Share 18 Tweet 11
  • New drug form may help treat osteoporosis, calcium-related disorders

    39 shares
    Share 16 Tweet 10
  • People living with HIV face premature heart disease and barriers to care

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

Chemistry/Physics/Materials SciencesTechnology/Engineering/Computer ScienceCell BiologycancerPublic HealthMaterialsClimate ChangeGeneticsEcology/EnvironmentMedicine/HealthBiologyInfectious/Emerging Diseases

Recent Posts

  • Eliminating microplastics in wastewater directly at the source
  • Where COVID-19 hit hardest, sudden deaths outside the hospital increased
  • Many parents say teens with anxiety, depression may benefit from peer confidants at school
  • Scientists shed light on how and why some people report “hearing the dead”
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In